pile of various medicines and pills
blue and green swoosh banner

A full course of BV treatment
in one oral dose1

Solosec® (secnidazole) is the first and only antibiotic treatment for bacterial vaginosis (BV) designed to deliver a complete course of therapy in just one oral dose1,2

solosec granule packet poured into yogurt

Treatment completion can be challenging to your BV patients for many reasons.2-4

Solosec offers them an easy one-dose oral treatment option that may potentially improve adherence.5

women icon

Even though BV is common, treatment can be challenging. Find out why.2-4

Explore BV Challenges

bar graph icon

Solosec was proven to be effective in pivotal trials.1,6,7

View Efficacy Trials

line graph icon

Learn how Solosec delivers potent antimicrobial activity in a single dose.1,5

See Pharmacokinetic Properties

1x icon

Solosec is easy to take—a full course of treatment in one oral dose.1,8

Dosing Explained

solosec oral granules packet


Get more information about how single-dose Solosec can help your patients.1

Learn More


  1. SOLOSEC [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc; 2017.
  2. Broumas AG, Basara LA. Potential patient preference for 3-day treatment of bacterial vaginosis: responses to new suppository form of clindamycin. Adv Ther. 2000;17(3):159-166.
  3. Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment guidelines, 2015. Morbid Mortal Wkly Rep (MMWR). 2015;64(3):1-140.
  4. Data on File, Patient Research. Symbiomix, a Lupin Company. 2013.
  5. Nyirjesy P, Schwebke JR. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment. Future Microbiol. 2018; 13:507-524. doi: 10.2217/fmb-2017-0270.
  6. Schwebke JR, Morgan FG Jr, Koltun W, Nyirjesy P. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Am J Obstet Gynecol. 2017;217(6):678.e1-678.e9. doi: 10.1016/j.ajog.2017.08.017.
  7. Hillier SL, Nyirjesy P, Waldbaum AS, et al. Secnidazole treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol. 2017;130(2):379-386.
  8. Data on File, Physician Research. Advantage Healthcare, Inc. Prepared December 23, 2014.